CC
AVR

Covalis Capital’s Anteris Technologies AVR Stock Holding History

Covalis Capital’s Portfolio AVR Stock Details AVR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50,000
Closed -$278K – 163
2026
Q1 		$278K Buy
+50,000
New +$287K 0.02% 118

Other funds holding AVR

LC
L1 Capital Melbourne VIC 3000, Australia $2.97B AUM 43.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Covalis Capital's AVR Position: Q2 2026 in Review

Covalis Capital sold out of Anteris Technologies (AVR) in Q2 2026, closing a stake of 50,000 shares — an estimated $278K sold.

Covalis Capital first reported a position in AVR in Q1 2026 and held it in 1 quarter. The position peaked at $278K in Q1 2026. 135 funds tracked by Wall St. Rank hold AVR as of Q2 2026.

  • Covalis Capital reported no remaining Anteris Technologies position as of Q2 2026 after selling out during the quarter.
  • Covalis Capital sold 50,000 Anteris Technologies shares in Q2 2026, an estimated $278K.
  • Covalis Capital first reported a position in Anteris Technologies in Q1 2026 and held it in 1 quarter.
  • Covalis Capital's Anteris Technologies position peaked at $278K in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Anteris Technologies as of Q2 2026.

Based on Covalis Capital's 13F filing for Q2 2026, filed 13 Aug 2026.